Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis
Hong Pu(Shanxi Medical University), Natasha Kyprianou(Icahn School of Medicine at Mount Sinai)
Cited by 28
Related Papers
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
|Cancer Research|2010|350
Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
|International Journal of Biological Sciences|2014|110
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
|The Prostate|2006|87
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
|Carcinogenesis|2014|67